Skip to content

Endurant® II ETLW1628C199E (UDI 00613994991362)Recalls & reported problems

Medtronic, Inc. · STENT GRAFT ETLW1628C199E ENDUR II LIMB · Class 3 · Implant

All models of Endurant II (114)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00613994991362), received between Mar 13, 2017 and Mar 13, 2017 — classified as 1 injury.

The most frequently reported specific device problem is “Leak/Splash” (1 report).

6 other recalls cover devices cleared under the same FDA submission (P100021); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Leak/Splash1

Patient problems

  • Injury1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 13, 2017Leak/Splash; Leak/Splash

    AN ENDURANT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM. IT WAS REPORTED THAT, APPROXIMATELY THREE YEARS AND NINE MONTHS POST INDEX PROCEDURE A CT REVEALED A DISTAL TYPE I ENDOLEAK IN THE ENDURANT STENT GRAFT LIMB. THE PHYSICIAN ELECTED TO EMBOLIZE THE RIGHT EXTERNAL ILIAC ARTERY AND IMPLANTED AN ENDURANT STENT GRAFT LIMB THAT EXTENDED INTO THE EXTERNAL ILIAC ARTERY. THE PROCEDURE WAS COMPLETED WITH THE DISTAL TYPE I ENDOLEAK SUCCESSFULLY EXCLUDED. PER THE PHYSICIAN, THE CAUSE OF THE EVENT WAS DUE TO DISEASE PROGRESSION IN THE ANEURYSMAL ILIAC ARTERY. THE DISEASE PROGRESSION LED THE ANEURYSMAL COMMON ILIAC ARTERY DIAMETER TO EXCEED THE 28 MM DIAMETER OF THE ENDURANT STENT GRAFT LIMB. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.

    Patient problems: Injury

    MAUDE report 6401365 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P100021. One submission often covers many models, so check the product and lot details in each record.

  • Z-0291-2022 · Oct 15, 2021 · Open, Classified
    Endurant II Stent Graft System REF/Description: ETBF2513C145EE STENT GRAFT ETBF2513C145EE ENDUR II BIF ETBF2820C166EE STENT GRAFT ETBF2820C166EE ENDUR II BIF ETBF2820C166EE STENT G
  • Z-0290-2022 · Oct 15, 2021 · Open, Classified
    Endurant Stent Graft System REF/Description: ENTF2525C70EE STENT GRAFT ENTF2525C70EE ENDURANT TUBE
  • Z-0292-2022 · Oct 15, 2021 · Open, Classified
    Endurant IIs Stent Graft System REF/Description: ESBF2814C103EE STENT GRAFT ESBF2814C103EE ENDUR IIS BIF ESBF2814C103EE STENT GRAFT ESBF2814C103EE ENDUR IIS BIF ESBF2814C103EE STEN
  • Z-2136-2021 · Jun 7, 2021 · Open, Classified
    Medtronic Endurant IIs Stent Graft System Medtronic Endurant IIs Stent Graft System REF ESBF3614C103EE and ESBF3214C103E. Used to treat infrarenal abdominal aortic or aortoili
  • Z-2135-2021 · Jun 7, 2021 · Open, Classified
    Endurant II/Endurant IIs Stent Graft System: Medtronic Endurant II Stent Graft System REF ETUF3214C102EE, ETCF3636C49EE, ETBF3216C166EE, and ETUF3614C102E. Used to treat infra
  • Z-1543-2017 · Feb 27, 2017 · Terminated
    Endurant / Endurant II 23mm and 25mm Bifurcated Stent Graft Systems Model Numbers: ETBF2516C145E ETBF2516C166E ETBF2316C145E ETBF2313C145E ETBF2513C166E ETBF2313C166E ETBF2316C166

Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices

All SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page